Go Pro
NASDAQ:ANL

Adlai Nortye (ANL) Stock Price, News & Analysis

Adlai Nortye logo
$12.86 -0.23 (-1.76%)
Closing price 04:00 PM Eastern
Extended Trading
$12.90 +0.04 (+0.35%)
As of 04:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Adlai Nortye Stock (NASDAQ:ANL)

Advanced

Key Stats

Today's Range
$12.50
$13.18
50-Day Range
$9.20
$13.84
52-Week Range
$0.88
$17.25
Volume
78,574 shs
Average Volume
412,418 shs
Market Capitalization
$514.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.25
Consensus Rating
Moderate Buy

Company Overview

Adlai Nortye Inc. (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control. Adlai Nortye’s global marketing and distribution network extends across Asia, Europe, North America and other regions, enabling the company to tailor products to diverse regulatory requirements and performance standards worldwide.

Since its founding in the mid-2000s, Adlai Nortye has pursued capacity expansions, new product development and strategic partnerships to strengthen its position in the fine chemicals sector. The leadership team, comprised of professionals with expertise in chemistry, engineering and international business, continues to advance initiatives designed to improve production efficiency, expand the product portfolio and enhance the company’s global market presence.

AI Generated. May Contain Errors.

Adlai Nortye Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

ANL MarketRank™: 

Adlai Nortye scored higher than 45% of companies evaluated by MarketBeat, and ranked 617th out of 911 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Adlai Nortye has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 5 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Adlai Nortye has a consensus price target of $24.25, representing about 88.6% upside from its current price of $12.86.

  • Amount of Analyst Coverage

    Adlai Nortye has only been the subject of 3 research reports in the past 90 days.

  • Read more about Adlai Nortye's stock forecast and price target.
  • Earnings Growth

    Earnings for Adlai Nortye are expected to decrease in the coming year, from ($0.32) to ($0.40) per share.

  • Percentage of Shares Shorted

    10.44% of the float of Adlai Nortye has been sold short.
  • Short Interest Ratio / Days to Cover

    Adlai Nortye has a short interest ratio ("days to cover") of 18.45, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Adlai Nortye has recently increased by 18.65%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Adlai Nortye does not currently pay a dividend.

  • Dividend Growth

    Adlai Nortye does not have a long track record of dividend growth.

  • News Sentiment

    Adlai Nortye has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Adlai Nortye this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for ANL on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Adlai Nortye to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Adlai Nortye insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $132.00 in company stock.

  • Percentage Held by Institutions

    35.21% of the stock of Adlai Nortye is held by institutions.

  • Read more about Adlai Nortye's insider trading history.
Receive ANL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ANL Stock News Headlines

Adlai Nortye: AN9025 Still Needs Human Validation
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
See More Headlines

ANL Stock Analysis - Frequently Asked Questions

Adlai Nortye's stock was trading at $1.42 at the beginning of the year. Since then, ANL stock has increased by 805.6% and is now trading at $12.86.

Adlai Nortye (ANL) raised $58 million in an initial public offering (IPO) on Friday, September 29th 2023. The company issued 2,500,000 shares at a price of $23.00 per share.

Shares of ANL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adlai Nortye investors own include PayPal (PYPL), Avino Silver & Gold Mines (ASM), nCino (NCNO), Construction Partners (ROAD), Taiwan Semiconductor Manufacturing (TSM), XPENG (XPEV) and Cogent Communications (CCOI).

Company Calendar

Today
8/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ANL
Previous Symbol
NASDAQ:ANL
CIK
1944552
Fax
N/A
Employees
127
Year Founded
2004

Price Target and Rating

High Price Target
$32.00
Low Price Target
$20.00
Potential Upside/Downside
+88.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.65
Quick Ratio
0.65

Sales & Book Value

Annual Sales
$5 million
Price / Sales
102.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.21) per share
Price / Book
-61.24

Miscellaneous

Outstanding Shares
40,000,000
Free Float
N/A
Market Cap
$514.40 million
Optionable
Not Optionable
Beta
1.06

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:ANL) was last updated on 8/13/2026 by MarketBeat.com Staff.
From Our Partners